James Wheatcroft

GSK Board Member

James Wheatcroft is the head of Finance for Research and Medicinal Sciences & Technology at GSK R&D – the role is accountable for financial management to GSK’s early stage drug discovery and related technologies.


During his career with GSK, James has held roles in Corporate, Commercial and R&D, including Head of Corporate Development, a series of commercial market FD roles in Asia, Aus/NZ and UK/Ireland, as well as Financial Controller for GSK R&D immediately prior to his current appointment in 2019.


James is a scientist by training and first joined GSK as a research chemist after completing his BSc at Bristol University.  He is a member of the Royal Society of Chemistry and the Chartered Institute of Management Accountants.

Go back to Board and Team

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.